James J. Collins

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Timothy Lu, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James J. Collins:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 30,000 17 Jun 2024 Direct
Senti Biosciences, Inc. Director Stock Option (Right to Buy) 21,950 25 Jun 2025 Direct
Orion Biotech Opportunities Corp. Director Class B ordinary shares 0 17 May 2023 Direct

Insider Reports Filed by James J. Collins

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNTI Senti Biosciences, Inc. 25 Jun 2025 1 $0 4 Director 27 Jun 2025, 19:55
SNTI Senti Biosciences, Inc. 07 Mar 2025 1 $0 4 Director 11 Mar 2025, 16:20
SNTI Senti Biosciences, Inc. 10 Jul 2024 1 $0 4 Director 12 Jul 2024, 16:16
FULC Fulcrum Therapeutics, Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:20
FULC Fulcrum Therapeutics, Inc. 27 Jun 2023 1 $0 4 Director 29 Jun 2023, 16:16
SNTI Senti Biosciences, Inc. 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 19:13
/report/000121390023041168-collins-james-j-2023-05-17 Orion Biotech Opportunities Corp. 17 May 2023 1 $0 4 Director 18 May 2023, 16:05
SNTI Senti Biosciences, Inc. 13 Jul 2022 1 $0 4 Director 15 Jul 2022, 18:00
FULC Fulcrum Therapeutics, Inc. 27 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:00
SNTI Senti Biosciences, Inc.\ 08 Jun 2022 0 $0 3 Director 15 Jun 2022, 18:01
FULC Fulcrum Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:11
/report/000121390021025867-collins-james-j-2021-05-12 Orion Biotech Opportunities Corp. 12 May 2021 0 $0 3 Director 12 May 2021, 20:15